MES and PN preclinical genetic models of GBM driven by NF1 loss and PDGFB overexpression, respectively, demonstrate differential responses to radiation (RT) and TMZ whereby the PDGFB overexpression phenotype is more sensitive compared to the NF1 loss phenotype [92]. Here, NF1 is linked to glioblastoma.